Lung Cancer Screening Program

About 228,820 new cases of lung cancer will be diagnosed in the US in 2020.

Lung cancer is the second most common cancer in both men and women (not counting skin cancer), and the leading cause of cancer death among both men and women.

Unfortunately, by the time most lung cancers are detected, they have already spread widely and are at an advanced stage. This makes cancer difficult to treat or cure.

Harrington offers an Early Detection Lung Cancer Screening Program which can detect lung cancer at an earlier stage, often making the disease more treatable. Our program engages the patient with a collaborative team including physicians, surgeons, radiologists, oncologists and pulmonologists to detect, diagnose and collaborate on an individualized care plan.

Listen: Jean Comeau, RN, Navigator for our Early Detection Screening Program, talks about the guidelines and benefits.

In 2019, Harrington’s Lung Cancer Program earned Accreditation by the American College of Radiology. In 2020, Harrington’s Lung Cancer Program earned a Center of Excellence award from the GO2 Foundation for Lung Cancer.

Do I Qualify for the Program?
What Kind of Test is Performed?
Is the Test Covered by My Insurance?
Cessation Resources

Program Success

Since the program began in 2015, Harrington has completed the following number of scans:
2015: 369
2016: 732
2017: 923
2018: 1,144
2019: 1,280
2020 (Fiscal): 1,437

Fiscal 2020 Findings
Fiscal 2019 Findings
Fiscal 2018 Findings
2017 Findings
UMass Memorial Healthcare


I Want To...

Find a Doctor Patient
Book Online Pay My Bill Get Directions Donate

© 2024 UMass Memorial Health